MINGXING TENG to Protein Kinase Inhibitors
This is a "connection" page, showing publications MINGXING TENG has written about Protein Kinase Inhibitors.
Connection Strength
0.849
-
Development of CDK2 and CDK5 Dual Degrader TMX-2172. Angew Chem Int Ed Engl. 2020 08 10; 59(33):13865-13870.
Score: 0.458
-
Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 05 24; 384(6698):885-890.
Score: 0.151
-
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. J Med Chem. 2022 06 09; 65(11):7581-7594.
Score: 0.131
-
Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation. Cell Chem Biol. 2019 11 21; 26(11):1486-1500.
Score: 0.110